These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 1731053

  • 1. Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
    Evans WE, Rodman JH, Relling MV, Petros WP, Stewart CF, Pui CH, Rivera GK.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):71-7. PubMed ID: 1731053
    [Abstract] [Full Text] [Related]

  • 2. Variability in teniposide plasma protein binding is correlated with serum albumin concentrations.
    Petros WP, Rodman JH, Relling MV, Christensen M, Pui CH, Rivera GK, Evans WE.
    Pharmacotherapy; 1992 Jan; 12(4):273-7. PubMed ID: 1518726
    [Abstract] [Full Text] [Related]

  • 3. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia.
    Yang L, Panetta JC, Cai X, Yang W, Pei D, Cheng C, Kornegay N, Pui CH, Relling MV.
    J Clin Oncol; 2008 Apr 20; 26(12):1932-9. PubMed ID: 18421047
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB, Jusko WJ, Rasmussen M, Schmiegelow K.
    Cancer Chemother Pharmacol; 2003 Jun 20; 51(6):465-73. PubMed ID: 12698270
    [Abstract] [Full Text] [Related]

  • 5. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS, Holdsworth MT, Devidas M, Raisch DW, Chauvenet A, Ravindranath Y, Ducore JM, Amylon MD.
    Pediatr Blood Cancer; 2006 Feb 20; 46(2):179-86. PubMed ID: 16007607
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
    Kearns CM, Blakley RL, Santana VM, Crom WR.
    Cancer Res; 1994 Mar 01; 54(5):1235-9. PubMed ID: 7906999
    [Abstract] [Full Text] [Related]

  • 7. Escalating teniposide systemic exposure to increase dose intensity for pediatric cancer patients.
    Rodman JH, Furman WL, Sunderland M, Rivera G, Evans WE.
    J Clin Oncol; 1993 Feb 01; 11(2):287-93. PubMed ID: 8426206
    [Abstract] [Full Text] [Related]

  • 8. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Feb 01; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 9. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
    Tedeschi A, Montillo M, Strocchi E, Cafro AM, Tresoldi E, Intropido L, Nichelatti M, Marbello L, Baratè C, Camaggi CM, Morra E.
    Cancer Chemother Pharmacol; 2007 May 01; 59(6):771-9. PubMed ID: 17256136
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, van 't Veer MB, Rammeloo JA, de Koning J, van Zanen GE.
    Am J Pediatr Hematol Oncol; 1989 May 01; 11(2):125-33. PubMed ID: 2665546
    [Abstract] [Full Text] [Related]

  • 11. Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimen.
    Bassan R, Battista R, Viero P, Pogliani E, Rossi G, Lambertenghi-Deliliers G, Rambaldi A, D'Emilio A, Buelli M, Borleri G.
    Semin Oncol; 1993 Dec 01; 20(6 Suppl 8):39-46. PubMed ID: 7507263
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients.
    Rodman JH, Sunderland M, Kavanagh RL, Ochs J, Yalowich J, Evans WE, Rivera GK.
    Cancer Res; 1990 Jul 15; 50(14):4267-71. PubMed ID: 2194652
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse.
    Hijiya N, Stewart CF, Zhou Y, Campana D, Coustan-Smith E, Rivera GK, Relling MV, Pui CH, Gajjar A.
    Cancer; 2008 May 01; 112(9):1983-91. PubMed ID: 18318429
    [Abstract] [Full Text] [Related]

  • 14. Increased teniposide clearance with concomitant anticonvulsant therapy.
    Baker DK, Relling MV, Pui CH, Christensen ML, Evans WE, Rodman JH.
    J Clin Oncol; 1992 Feb 01; 10(2):311-5. PubMed ID: 1732431
    [Abstract] [Full Text] [Related]

  • 15. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    Sato Y, Ito R, Saito T, Suto Y, Tateoka N, Onodera N, Ikeda Y, Ito E, Miyano T, Tachibana N.
    Rinsho Ketsueki; 1989 Nov 01; 30(11):1923-30. PubMed ID: 2607611
    [Abstract] [Full Text] [Related]

  • 16. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM, Stork L, Seibel N, Sarquis M, Bedros C, Sather H, Sensel M, Reaman GH, Gaynon PS.
    Clin Cancer Res; 2000 Aug 01; 6(8):3123-30. PubMed ID: 10955793
    [Abstract] [Full Text] [Related]

  • 17. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
    Maslak P, Hegewisch-Becker S, Godfrey L, Andreeff M.
    Cytometry; 1994 Sep 01; 17(1):84-93. PubMed ID: 8001461
    [Abstract] [Full Text] [Related]

  • 18. A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia.
    Rizzari C, Citterio M, Zucchetti M, Conter V, Chiesa R, Colombini A, Malguzzi S, Silvestri D, D'Incalci M.
    Haematologica; 2006 Jan 01; 91(1):24-31. PubMed ID: 16434367
    [Abstract] [Full Text] [Related]

  • 19. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X, Li Q, Zhu YP, Zhou CY, Gao J, Li XH, Pan LL, Li FY, Tian X, Liu HT.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct 01; 24(5):560-3. PubMed ID: 17922427
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R.
    Exp Hematol; 1995 Dec 01; 23(14):1553-62. PubMed ID: 8542946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.